Skip to main content
Erschienen in: Digestive Diseases and Sciences 9/2011

01.09.2011 | Original Article

Continuous Peritoneal Drainage of Large-Volume Ascites

verfasst von: David H. Van Thiel, Christopher M. Moore, Moises Garcia, Magdalena George, Abdul Nadir

Erschienen in: Digestive Diseases and Sciences | Ausgabe 9/2011

Einloggen, um Zugang zu erhalten

Abstract

Background

With the increasing population of individuals with cirrhosis, many of whom are not liver transplant candidates, large volume paracentesis as a medical therapy for ascites resistant to diuretic therapy has become increasingly utilized.

Aim

To determine the safety and efficacy of continuous peritoneal drainage of large-volume ascites in Child Class-C cirrhosis. Subjects with no current clinical or laboratory findings of spontaneous bacterial ascites were studied. Each had a complete medical evaluation to document the etiology and severity of their liver disease as well as the identification of any confounding medical illness. A triple-phase abdominal CT of the abdomen was obtained in each individual to rule out any hepatoma. Upon completion of the above, a pericardiocentesis catheter was placed in the abdomen using the Seldinger technique and the ascites was drained continuously (to gravity) until no additional ascitic fluid could be removed or the total time of drainage was 72 h. The patient’s weight, volume of ascitic fluid removed, ascitic fluid cell counts, ascitic fluid cultures, complete blood count and comprehensive metabolic profile were obtained immediately before and after the peritoneal catheter was removed.

Results

HCV cirrhosis accounted for 12 cases and alcoholic liver disease accounted for 8 cases (half the total of 40 cases), with 6 other diseases accounting for the remaining half. The ascitic fluid was drained continuously for 2.5 ± 0.08 days, with a removal of 13.3 ± 0.5 l of ascitic fluid. No clinically significant change in the serum creatinine or ascitic fluid cells count occurred as a result of the procedure. The adverse effects of the procedure were minimal. 63% of the patients experienced some mild discomfort at the catheter insertion site, or local abdominal pain just prior to the removal of the catheter. Two patients developed a small abdominal wall hematoma that required no therapy. No patients experienced peritoneal hemorrhage, infection or renal dysfunction.

Conclusion

(1) Continuous large-volume peritoneal drainage by gravity is safe and effective; (2) if the procedure is limited 72 h, no cases of ascitic fluid contamination/infection occur; and (3) it reduces the time between subsequent paracentesis based upon historical data.
Literatur
1.
Zurück zum Zitat Runyon BA. Management of adult patients with ascites due to cirrhosis. Hepatology. 2004;39:841–856.PubMedCrossRef Runyon BA. Management of adult patients with ascites due to cirrhosis. Hepatology. 2004;39:841–856.PubMedCrossRef
2.
Zurück zum Zitat Runyon BA. Care of patients with ascites. N Eng J Med. 1994;300:337–342.CrossRef Runyon BA. Care of patients with ascites. N Eng J Med. 1994;300:337–342.CrossRef
3.
Zurück zum Zitat Sungaila I, Bartle WR, Walker SE, et al. Spironolactone pharmacokinetics and pharmacodynamics in patients with cirrhotic ascites. Gastroenterology. 1992;102:1680–1685.PubMed Sungaila I, Bartle WR, Walker SE, et al. Spironolactone pharmacokinetics and pharmacodynamics in patients with cirrhotic ascites. Gastroenterology. 1992;102:1680–1685.PubMed
4.
5.
Zurück zum Zitat Runyon BA. Paracentesis of ascitic fluid. A safe procedure. Arch Intern Med. 1986;146:2259–2261.PubMedCrossRef Runyon BA. Paracentesis of ascitic fluid. A safe procedure. Arch Intern Med. 1986;146:2259–2261.PubMedCrossRef
6.
Zurück zum Zitat Peltekian KM, Wong F, Liu PP, Logan AG, Sherman M, Blendis LM. Cardiovascular, renal, and neurohumoral responses to single large volume paracentesis in patients with cirrhosis and diuretic resistant ascites. Am J Gastroenterol. 1997;92:394–399.PubMed Peltekian KM, Wong F, Liu PP, Logan AG, Sherman M, Blendis LM. Cardiovascular, renal, and neurohumoral responses to single large volume paracentesis in patients with cirrhosis and diuretic resistant ascites. Am J Gastroenterol. 1997;92:394–399.PubMed
7.
Zurück zum Zitat Runyon BA. Patient selection is important in studying the impact of large-volume paracentesis on intravascular volume. Am J Gastroenterol. 1997;92:371–373.PubMed Runyon BA. Patient selection is important in studying the impact of large-volume paracentesis on intravascular volume. Am J Gastroenterol. 1997;92:371–373.PubMed
8.
Zurück zum Zitat Rössle M, Ochs A, Gülberg V, et al. A comparison of paracentesis and transjuglar intra-hepatic portosystemic shunting in patients with ascites. N Eng J Med. 2000;342:1745–1747.CrossRef Rössle M, Ochs A, Gülberg V, et al. A comparison of paracentesis and transjuglar intra-hepatic portosystemic shunting in patients with ascites. N Eng J Med. 2000;342:1745–1747.CrossRef
9.
Zurück zum Zitat Boyer TD, Haskal ZJ. The role of transjugualr intrahepatic portosystemic shunt in the management of portal hypertension. Hepatology. 2005;41:386–400.PubMedCrossRef Boyer TD, Haskal ZJ. The role of transjugualr intrahepatic portosystemic shunt in the management of portal hypertension. Hepatology. 2005;41:386–400.PubMedCrossRef
10.
Zurück zum Zitat Boyer TD. Transjugular intrahepatic portosystemic shunt: current status. Gastroenterology. 2003;124:1700–1710.PubMedCrossRef Boyer TD. Transjugular intrahepatic portosystemic shunt: current status. Gastroenterology. 2003;124:1700–1710.PubMedCrossRef
11.
Zurück zum Zitat Gines P, Arroyo V, Vargas V, et al. Paracentesis with intravenous infusion of albumin as compared with peritoneovenous shunting in cirrhosis with refractory ascites. N Engl J Med. 1991;325:829–835.PubMedCrossRef Gines P, Arroyo V, Vargas V, et al. Paracentesis with intravenous infusion of albumin as compared with peritoneovenous shunting in cirrhosis with refractory ascites. N Engl J Med. 1991;325:829–835.PubMedCrossRef
12.
Zurück zum Zitat Nadir A, Van Thiel DH. Frequency of peritoneal infections among patients undergoing continuous paracentesis with an indwelling catheter. J Ayb Med Coll. 2010;22:37–41. Nadir A, Van Thiel DH. Frequency of peritoneal infections among patients undergoing continuous paracentesis with an indwelling catheter. J Ayb Med Coll. 2010;22:37–41.
13.
Zurück zum Zitat Tito L, Gines P, Arroyo V, et al. Total paracentesis associated with intravenous albumin management of patients with cirrhosis and ascites. Gastroenterology. 1990;98:146–151.PubMed Tito L, Gines P, Arroyo V, et al. Total paracentesis associated with intravenous albumin management of patients with cirrhosis and ascites. Gastroenterology. 1990;98:146–151.PubMed
14.
Zurück zum Zitat Sakai H, Sheer TA, Mendler MH, Runyon BA. Choosing the location for non-image guided abdominal paracentesis. Liver Int. 2005;25:984–986.PubMedCrossRef Sakai H, Sheer TA, Mendler MH, Runyon BA. Choosing the location for non-image guided abdominal paracentesis. Liver Int. 2005;25:984–986.PubMedCrossRef
15.
Zurück zum Zitat Grabau CM, Crago SF, Hoff LK, et al. Performance standards for therapeutic abdominal paracentesis. Hepatology. 2004;40:484–488.PubMedCrossRef Grabau CM, Crago SF, Hoff LK, et al. Performance standards for therapeutic abdominal paracentesis. Hepatology. 2004;40:484–488.PubMedCrossRef
16.
Zurück zum Zitat McVay PA, Toy PT. Lack of increased bleeding after paracentesis and thoracentesis in patients with mild coagulation abnormalities. Transfusion. 1991;31:164–171.PubMedCrossRef McVay PA, Toy PT. Lack of increased bleeding after paracentesis and thoracentesis in patients with mild coagulation abnormalities. Transfusion. 1991;31:164–171.PubMedCrossRef
17.
Zurück zum Zitat Webster ST, Brown KL, Lucey MR, Nostrant TT. Hemorrhagic complications of large volume abdominal paracentesis. Am J Gastroenterol. 1996;91:366–368.PubMed Webster ST, Brown KL, Lucey MR, Nostrant TT. Hemorrhagic complications of large volume abdominal paracentesis. Am J Gastroenterol. 1996;91:366–368.PubMed
18.
Zurück zum Zitat Van Thiel DH, Hassanein T, Gurakar A, et al. Liver transplantation after an acute episode of spontaneous bacterial peritonitis. Hepatogastroenterology. 1996;43:1584–1588.PubMed Van Thiel DH, Hassanein T, Gurakar A, et al. Liver transplantation after an acute episode of spontaneous bacterial peritonitis. Hepatogastroenterology. 1996;43:1584–1588.PubMed
Metadaten
Titel
Continuous Peritoneal Drainage of Large-Volume Ascites
verfasst von
David H. Van Thiel
Christopher M. Moore
Moises Garcia
Magdalena George
Abdul Nadir
Publikationsdatum
01.09.2011
Verlag
Springer US
Erschienen in
Digestive Diseases and Sciences / Ausgabe 9/2011
Print ISSN: 0163-2116
Elektronische ISSN: 1573-2568
DOI
https://doi.org/10.1007/s10620-011-1792-x

Weitere Artikel der Ausgabe 9/2011

Digestive Diseases and Sciences 9/2011 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Erhebliches Risiko für Kehlkopfkrebs bei mäßiger Dysplasie

29.05.2024 Larynxkarzinom Nachrichten

Fast ein Viertel der Personen mit mäßig dysplastischen Stimmlippenläsionen entwickelt einen Kehlkopftumor. Solche Personen benötigen daher eine besonders enge ärztliche Überwachung.

Nach Herzinfarkt mit Typ-1-Diabetes schlechtere Karten als mit Typ 2?

29.05.2024 Herzinfarkt Nachrichten

Bei Menschen mit Typ-2-Diabetes sind die Chancen, einen Myokardinfarkt zu überleben, in den letzten 15 Jahren deutlich gestiegen – nicht jedoch bei Betroffenen mit Typ 1.

15% bedauern gewählte Blasenkrebs-Therapie

29.05.2024 Urothelkarzinom Nachrichten

Ob Patienten und Patientinnen mit neu diagnostiziertem Blasenkrebs ein Jahr später Bedauern über die Therapieentscheidung empfinden, wird einer Studie aus England zufolge von der Radikalität und dem Erfolg des Eingriffs beeinflusst.

Costims – das nächste heiße Ding in der Krebstherapie?

28.05.2024 Onkologische Immuntherapie Nachrichten

„Kalte“ Tumoren werden heiß – CD28-kostimulatorische Antikörper sollen dies ermöglichen. Am besten könnten diese in Kombination mit BiTEs und Checkpointhemmern wirken. Erste klinische Studien laufen bereits.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.